These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 30096367)

  • 1. Application of the comparison approach to open TG-GATEs: A useful toxicogenomics tool for detecting modes of action in chemical risk assessment.
    Heusinkveld HJ; Wackers PFK; Schoonen WG; van der Ven L; Pennings JLA; Luijten M
    Food Chem Toxicol; 2018 Nov; 121():115-123. PubMed ID: 30096367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of
    Luijten M; Wackers PFK; Rorije E; Pennings JLA; Heusinkveld HJ
    Chem Res Toxicol; 2021 Feb; 34(2):452-459. PubMed ID: 33378166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel transcriptomics based in vitro method to compare and predict hepatotoxicity based on mode of action.
    De Abrew KN; Overmann GJ; Adams RL; Tiesman JP; Dunavent J; Shan YK; Carr GJ; Daston GP; Naciff JM
    Toxicology; 2015 Feb; 328():29-39. PubMed ID: 25475144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens.
    Schaap MM; Wackers PF; Zwart EP; Huijskens I; Jonker MJ; Hendriks G; Breit TM; van Steeg H; van de Water B; Luijten M
    Arch Toxicol; 2015 Dec; 89(12):2413-27. PubMed ID: 25270620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DTNI: a novel toxicogenomics data analysis tool for identifying the molecular mechanisms underlying the adverse effects of toxic compounds.
    Hendrickx DM; Souza T; Jennen DGJ; Kleinjans JCS
    Arch Toxicol; 2017 Jun; 91(6):2343-2352. PubMed ID: 28032149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicogenomics directory of rat hepatotoxicants in vivo and in cultivated hepatocytes.
    Grinberg M; Stöber RM; Albrecht W; Edlund K; Schug M; Godoy P; Cadenas C; Marchan R; Lampen A; Braeuning A; Buhrke T; Leist M; Oberemm A; Hellwig B; Kamp H; Gardner I; Escher S; Taboureau O; Aguayo-Orozco A; Sachinidis A; Ellinger-Ziegelbauer H; Rahnenführer J; Hengstler JG
    Arch Toxicol; 2018 Dec; 92(12):3517-3533. PubMed ID: 30511339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human hepatocyte TXG-MAPr: gene co-expression network modules to support mechanism-based risk assessment.
    Callegaro G; Kunnen SJ; Trairatphisan P; Grosdidier S; Niemeijer M; den Hollander W; Guney E; Piñero Gonzalez J; Furlong L; Webster YW; Saez-Rodriguez J; Sutherland JJ; Mollon J; Stevens JL; van de Water B
    Arch Toxicol; 2021 Dec; 95(12):3745-3775. PubMed ID: 34626214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parallelogram approach using rat-human in vitro and rat in vivo toxicogenomics predicts acetaminophen-induced hepatotoxicity in humans.
    Kienhuis AS; van de Poll MC; Wortelboer H; van Herwijnen M; Gottschalk R; Dejong CH; Boorsma A; Paules RS; Kleinjans JC; Stierum RH; van Delft JH
    Toxicol Sci; 2009 Feb; 107(2):544-52. PubMed ID: 19008212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development.
    Blomme EA; Yang Y; Waring JF
    Toxicol Lett; 2009 Apr; 186(1):22-31. PubMed ID: 18996174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LTMap: a web server for assessing the potential liver toxicity by genome-wide transcriptional expression data.
    Xing L; Wu L; Liu Y; Ai N; Lu X; Fan X
    J Appl Toxicol; 2014 Jul; 34(7):805-9. PubMed ID: 24022982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific differences in coumarin-induced hepatotoxicity as an example toxicogenomics-based approach to assessing risk of toxicity to humans.
    Uehara T; Kiyosawa N; Shimizu T; Omura K; Hirode M; Imazawa T; Mizukawa Y; Ono A; Miyagishima T; Nagao T; Urushidani T
    Hum Exp Toxicol; 2008 Jan; 27(1):23-35. PubMed ID: 18480146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A toxicogenomics-based parallelogram approach to evaluate the relevance of coumarin-induced responses in primary human hepatocytes in vitro for humans in vivo.
    Kienhuis AS; van de Poll MC; Dejong CH; Gottschalk R; van Herwijnen M; Boorsma A; Kleinjans JC; Stierum RH; van Delft JH
    Toxicol In Vitro; 2009 Sep; 23(6):1163-9. PubMed ID: 19527782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of 12 mouse marker genes in rat toxicogenomics public data, Open TG-GATEs: Discrimination of genotoxic from non-genotoxic hepatocarcinogens.
    Furihata C; Suzuki T
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Feb; 838():9-15. PubMed ID: 30678831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of genotoxicant-modified transcriptomic responses in conventional and epigenetically stabilized primary rat hepatocytes with in vivo rat liver data.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Nov; 86(11):1703-15. PubMed ID: 23052194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Addressing systematic inconsistencies between in vitro and in vivo transcriptomic mode of action signatures.
    McMullen PD; Pendse SN; Black MB; Mansouri K; Haider S; Andersen ME; Clewell RA
    Toxicol In Vitro; 2019 Aug; 58():1-12. PubMed ID: 30807807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
    Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
    Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Chronic Drug Effects on Microengineered Human Liver Cultures Using Global Gene Expression Profiling.
    Ware BR; McVay M; Sunada WY; Khetani SR
    Toxicol Sci; 2017 Jun; 157(2):387-398. PubMed ID: 28369597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.
    Eichner J; Wrzodek C; Römer M; Ellinger-Ziegelbauer H; Zell A
    PLoS One; 2014; 9(5):e97678. PubMed ID: 24828355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Literature-based compound profiling: application to toxicogenomics.
    Frijters R; Verhoeven S; Alkema W; van Schaik R; Polman J
    Pharmacogenomics; 2007 Nov; 8(11):1521-34. PubMed ID: 18034617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.